reports
Wereldhave Nv: 2 directors
Two Directors at Wereldhave Nv bought 50,425 shares at 13.100EUR. The significance rating of the trade was 89/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Kuros Biosciences Ag: 1 director
A director at Kuros Biosciences Ag sold 7,181 shares at 6.955CHF and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Compagnie Financière Tradition S.A.: 1 director
A director at Compagnie Financière Tradition S.A. sold 184 shares at 144.000CHF and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
- Russell Waller
Swisscom (Neutral, TP: CHF610, +22%) Q1 24:Mixed numbers, weaker SR ...
Swisscom has reported a slightly mixed set of numbers. Swiss SR trends have deteriorated faster than expected; EBITDA is more in-line, but OpFCF and FCF are both light. We worry that Swiss SR trends will come under further pressure in the run-up to the Sunrise IPO, and as Salt starts to offer a fixed product to more of the country.
Pitney Bowes Declares Common Stock Dividend
STAMFORD, Conn.--(BUSINESS WIRE)-- Pitney Bowes Inc. (NYSE:PBI), a global shipping and mailing company that provides technology, logistics, and financial services, today announced that its Board of Directors has declared a quarterly cash dividend on the company’s common stock of $0.05 per share. The dividend will be paid on June 7, 2024 to stockholders of record on May 23, 2024. About Pitney Bowes Pitney Bowes (NYSE:PBI) is a global shipping and mailing company that provides technology, logistics, and financial services to more than 90 percent of the Fortune 500. Small business, retail, en...
EQS-News: MEDICLIN steigert Konzernumsatz und Betriebsergebnis im erst...
EQS-News: MEDICLIN AG / Schlagwort(e): Quartals-/Zwischenmitteilung MEDICLIN steigert Konzernumsatz und Betriebsergebnis im ersten Quartal 2024 02.05.2024 / 13:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Offenburg, 2. Mai 2024 MEDICLIN steigert Konzernumsatz und Betriebsergebnis im ersten Quartal 2024 MEDICLIN steigert seinen Konzernumsatz für das erste Quartal 2024 um 4,9 % auf 185,4 Mio. Euro Konzern-EBIT mit 4,1 Mio. Euro deutlich höher als im Vorjahreszeitraum (-1,7 Mio. Euro) Auslastung mit 85,1 % gegenüber Vorjahr ge...
EQS-News: MEDICLIN increases consolidated sales and operating result i...
EQS-News: MEDICLIN AG / Key word(s): Quarterly / Interim Statement MEDICLIN increases consolidated sales and operating result in the first quarter of 2024 02.05.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. Offenburg, 2 May 2024 MEDICLIN increases consolidated sales and operating result in the first quarter of 2024 MEDICLIN increases its consolidated sales for the first quarter of 2024 by 4.9% to EUR 185.4 million Group EBIT of EUR 4.1 million significantly higher than in the same period of the previous year (EUR -1.7 m...
- Dan Salmon
Match Group (MTCH, Buy, $55 target) Quick Thoughts Ahead of Tuesday’s...
Ahead of Tuesday PM’s earnings report, we review key controversies for MTCH, including: 1. Tinder payers: the moment of truth approaches 2. The path to $1 billion in revenue for Hinge 3. Will MTCH outspend the 50% of FCF target for share buybacks again in 2024? We also review what to look for in the investor letter and listen for on the earnings call, our top questions for management, and potential positive and negative catalysts for MTCH.
Kimco Realty® Announces First Quarter 2024 Results
Kimco Realty® Announces First Quarter 2024 Results – Strong Growth and Leasing Activity – – Successful Execution on RPT Realty Acquisition – – Board Declares Quarterly Dividend – – Updates 2024 Outlook – JERICHO, N.Y., May 02, 2024 (GLOBE NEWSWIRE) -- Kimco Realty® (NYSE: KIM), a real estate investment trust (REIT) and leading owner and operator of high-quality, open-air, grocery-anchored shopping centers and mixed-use properties in the United States, today reported results for the first quarter ended March 31, 2024. For the three months ended March 31, 2024 and 2023, Kimco Realty’s n...
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent ...
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights - Completed additional enrollment in Phase 1B dose-expansion cohorts for TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) patients in the first quarter of 2024; updated combination data expected at the European Society of Hematology (EHA) 2024 Annual Meeting in June – - Randomized, controlled Phase 1B dose-expansion cohort in frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) patients expected to initiate enrollment in the second quarter of 2024 – - Presented preclinical data at the 2024 Americ...
Appian Announces First Quarter 2024 Financial Results
Appian Announces First Quarter 2024 Financial Results First quarter cloud subscription revenue increased 24% year-over-year to $86.6 million MCLEAN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) today announced financial results for the first quarter ended March 31, 2024. “Appian continues to push technological boundaries in our industry, from AI-backed services to process mining. Organizations globally are recognizing the power and simplicity of the Appian Platform,” said Matt Calkins, CEO & Founder. First Quarter 2024 Financial Highlights: Revenue: Cloud subscription ...
Gilat to Participate in the 19th Annual Needham Technology, Media & Co...
Gilat to Participate in the 19th Annual Needham Technology, Media & Consumer Conference on May 15, 2024 PETAH TIKVA, Israel, May 02, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, today announced management’s participation in the 19th Annual Needham Technology, Media and Consumer Conference at the Westin Grand Central Hotel in New York City. Mr. Adi Sfadia, the Company’s CEO, and Mr. Gil Benyamini, the Company’s CFO, will be available for one-on-one meetings with investors at the...
Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Fina...
ROOT, Switzerland--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR) announced today that it has entered into a new five-year up to $400 million committed senior secured credit facility with funds managed by Pharmakon Advisors, LP. The committed capital will be available to Novocure in four tranches of $100 million. The first $100 million was issued at closing, and the second $100 million will be issued by June 30, 2025. An additional $200 million is available to be drawn across two tranches, at Novocure’s discretion and subject to certain milestones, through March 31, 2026. The proceeds will be used ...
Sotera Health Reports First-Quarter 2024 Results
Sotera Health Reports First-Quarter 2024 Results Q1 2024 net revenues increased 12.5% to $248 million, compared to Q1 2023Q1 2024 net income of $6 million or $0.02 per diluted share, compared to net income of $3 million or $0.01 per diluted share in Q1 2023Q1 2024 Adjusted EBITDA(1) increased 13.7% to $112 million, compared to Q1 2023Q1 2024 Adjusted EPS(1) of $0.13 compared to Adjusted EPS of $0.13 in Q1 2023Company reaffirms 2024 outlook CLEVELAND, May 02, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of missi...
Editas Medicine Announces First Quarter 2024 Results Conference Call a...
Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that it will host a conference call and webcast on Wednesday, May 8, 2024, at 8:00 a.m. ET to discuss results for the first quarter 2024 and to provide a corporate update. To access the conference call: U.S. callers should dial and international callers should dial approximately five minutes before the call begins.Participants should ask to be c...
OneWater Marine Inc. Announces Fiscal Second Quarter 2024 Results
OneWater Marine Inc. Announces Fiscal Second Quarter 2024 Results Maintaining previously issued fiscal full year 2024 outlook Fiscal Second Quarter 2024 Highlights Revenue decreased 7% to $488 millionSame-store sales decreased 5% for the quarter; average annual increase of 4% over last two yearsGross profit margin of 24.6%GAAP net loss of $(5) million, or $(0.27) per diluted share and adjusted diluted earnings per share1 of $0.67Adjusted EBITDA1 was $28 million BUFORD, Ga., May 02, 2024 (GLOBE NEWSWIRE) -- OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or the “Company”) t...
Aya Gold & Silver Announces At-Depth Drill Results at Zgounder Provide...
Aya Gold & Silver Announces At-Depth Drill Results at Zgounder Provides Notice of Q1-2024 Results and Conference Call MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce high-grade silver drill results from its at-depth drill exploration program at the Zgounder Silver Mine in the Kingdom of Morocco. Key Highlights (all intersections are in core lengths) In the Central Zone from the 1,950m level: hole ZG-SF-24-107 intercepted 1,459 grams per tonne (“g/t”) silver (“Ag”) over 5.5 m...
Aya Or & Argent annonce des résultats de forage en profondeur à Zgound...
Aya Or & Argent annonce des résultats de forage en profondeur à Zgounder ainsi que la date de la conférence téléphonique sur les résultats du T1-2024 MONTRÉAL, 02 mai 2024 (GLOBE NEWSWIRE) -- Aya Or & Argent Inc. (TSX : AYA; OTCQX : AYASF) (« Aya » ou la « Société ») a le plaisir d’annoncer des résultats de forage à haute teneur en argent dans le cadre de son programme de forage d’exploration en profondeur à la mine d’argent Zgounder dans le Royaume du Maroc. Principaux faits saillants (toutes les intersections sont en longueur dans l’axe de forage) Dans la zone Centrale, à ...
BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M o...
BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M of private external capital to accelerate the development of its novel precision oncology pipeline The oversubscribed financing was led by Cormorant Asset Management and co-led by Omega Funds with participation from affiliates of Deerfield Management, GV (Google Ventures), EcoR1 Capital, Wellington Management, Enavate Sciences, Surveyor Capital (a Citadel company), Aisling Capital, Casdin Capital, and Longwood FundThis capital raise provides BBOT with runway to achieve significant clinical inflection points over the next 1...
Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference
Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference TEL AVIV, Israel, May 02, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that Chief Executive Officer Dr. Adi Mor will deliver a corporate presentation at the Aegis Virtual Conference on May 7, 2024 at 9:00 am ET. Dr. Mor’s presentation will be webcast live. The registration link to access the live presentation is included below and is also available ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.